Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malik Y Kahook

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Middle East African Journal of Ophthalmology|February 10, 2010
Glaucoma surgery: how do we get from here to there?Malik Y Kahook
American Journal of Ophthalmology|June 24, 2010
Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot studyMalik Y Kahook
Expert Review of Medical Devices|March 16, 2007
Developments in dosing aids and adherence devices for glaucoma therapy: current and future perspectivesMalik Y Kahook
Journal of Cataract and Refractive Surgery|December 24, 2014
December consultation #7Malik Y Kahook
Journal of Cataract and Refractive Surgery|July 3, 2019
Consultation Section: Glaucoma. July consultation #7Malik Y Kahook
Advances in Therapy|August 2, 2008
Quantitative analysis of conjunctival goblet cells after chronic application of topical dropsMalik Y Kahook, Robert Noecker
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 23, 2010
In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cellsMalik Y Kahook, David A Ammar
Journal of Cataract and Refractive Surgery|June 17, 2020
Long-term follow-up and clinical evaluation of the light-adjustable intraocular lens implanted after cataract removal: 7-year resultsJennifer L Patnaik, Malik Y Kahook
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Effects of prostaglandin analog therapy on the ocular surface of glaucoma patientsMichael B Horsley, Malik Y Kahook
Cornea|March 26, 2008
Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tearsMalik Y Kahook, Robert J Noecker
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Middle East African Journal of Ophthalmology|February 10, 2010
Glaucoma surgery: how do we get from here to there?Malik Y Kahook
American Journal of Ophthalmology|June 24, 2010
Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot studyMalik Y Kahook
Expert Review of Medical Devices|March 16, 2007
Developments in dosing aids and adherence devices for glaucoma therapy: current and future perspectivesMalik Y Kahook
Journal of Cataract and Refractive Surgery|December 24, 2014
December consultation #7Malik Y Kahook
Journal of Cataract and Refractive Surgery|July 3, 2019
Consultation Section: Glaucoma. July consultation #7Malik Y Kahook
Advances in Therapy|August 2, 2008
Quantitative analysis of conjunctival goblet cells after chronic application of topical dropsMalik Y Kahook, Robert Noecker
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 23, 2010
In vitro toxicity of topical ocular prostaglandin analogs and preservatives on corneal epithelial cellsMalik Y Kahook, David A Ammar
Journal of Cataract and Refractive Surgery|June 17, 2020
Long-term follow-up and clinical evaluation of the light-adjustable intraocular lens implanted after cataract removal: 7-year resultsJennifer L Patnaik, Malik Y Kahook
Clinical Ophthalmology (Auckland, N.Z.)|August 12, 2009
Effects of prostaglandin analog therapy on the ocular surface of glaucoma patientsMichael B Horsley, Malik Y Kahook
Cornea|March 26, 2008
Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tearsMalik Y Kahook, Robert J Noecker
Pageof 21